Rockwell Med(DE:RWM)
€0.450.00 (0.00%)
DE:RWM
Rockwell Med financials statements
€0.45
At close:0.00 (0.00%)
Rockwell Med (RWM) Ratios
3 Followers
Rockwell Med Ratios
DE:RWM's free cash flow for Q3 2026 was $-484.00K. For the 2026 fiscal year, DE:RWM's free cash flow was increased by $1.04M and operating cash flow was $-1.53M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.98 | 2.63 | 1.73 | 2.00 | 1.68 |
| Quick Ratio | 3.63 | 2.22 | 1.38 | 1.67 | 1.49 |
| Cash Ratio | 1.12 | 1.11 | 0.54 | 0.57 | 0.63 |
| Solvency Ratio | -0.15 | 0.06 | -0.23 | -0.56 | -0.66 |
| Operating Cash Flow Ratio | -0.07 | 0.30 | -0.57 | -0.96 | -1.60 |
| Short-Term Operating Cash Flow Coverage | -2.50 | 15.68 | -38.57 | -7.93 | -4.29 |
| Net Current Asset Value | $ 18.00M | $ 10.41M | $ -2.11M | $ 2.78M | $ -10.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.23 | 0.26 | 0.35 | 0.59 |
| Debt-to-Equity Ratio | 0.34 | 0.42 | 0.63 | 1.16 | 11.40 |
| Debt-to-Capital Ratio | 0.25 | 0.29 | 0.39 | 0.54 | 0.92 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.21 | 0.28 | 0.35 | 0.84 |
| Financial Leverage Ratio | 1.55 | 1.82 | 2.45 | 3.31 | 19.16 |
| Debt Service Coverage Ratio | -1.44 | 1.94 | -1.84 | -3.97 | -2.73 |
| Interest Coverage Ratio | -4.17 | 0.48 | -2.90 | -8.67 | -12.85 |
| Debt to Market Cap | 0.30 | 0.14 | 0.19 | 0.97 | 0.55 |
| Interest Debt Per Share | 3.78 | 4.76 | 0.67 | 1.85 | 3.67 |
| Net Debt to EBITDA | -0.88 | -0.72 | -0.95 | -0.39 | -0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.89% | 17.23% | 10.41% | 5.60% | -3.91% |
| EBIT Margin | -6.05% | 0.76% | -7.34% | -23.00% | -48.95% |
| EBITDA Margin | -2.88% | 2.91% | -5.61% | -22.20% | -44.89% |
| Operating Profit Margin | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% |
| Pretax Profit Margin | -7.67% | -0.47% | -10.09% | -25.65% | -52.76% |
| Net Profit Margin | -7.67% | -0.47% | -10.09% | -25.65% | -52.76% |
| Continuous Operations Profit Margin | -7.67% | -0.47% | -10.09% | -25.65% | -52.76% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 113.28% | -78.95% | 126.52% | 111.32% | 107.71% |
| Return on Assets (ROA) | -9.30% | -0.81% | -16.18% | -40.05% | -67.27% |
| Return on Equity (ROE) | -14.37% | -1.47% | -39.64% | -132.42% | -1288.92% |
| Return on Capital Employed (ROCE) | -9.86% | 1.35% | -18.77% | -57.97% | -109.88% |
| Return on Invested Capital (ROIC) | -9.49% | 1.28% | -17.68% | -50.72% | -81.05% |
| Return on Tangible Assets | -11.41% | -1.00% | -20.84% | -40.86% | -68.57% |
| Earnings Yield | -17.71% | -0.76% | -19.14% | -187.44% | -84.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.51 | 12.24 | 7.67 | 11.63 | 10.47 |
| Payables Turnover | 28.80 | 29.28 | 16.59 | 16.96 | 17.21 |
| Inventory Turnover | 16.81 | 14.54 | 12.76 | 11.82 | 15.79 |
| Fixed Asset Turnover | 8.82 | 9.81 | 7.59 | 8.46 | 6.06 |
| Asset Turnover | 1.21 | 1.71 | 1.60 | 1.56 | 1.27 |
| Working Capital Turnover Ratio | 2.69 | 5.79 | 5.62 | 4.56 | 1.74 |
| Cash Conversion Cycle | 51.95 | 42.46 | 54.19 | 40.73 | 36.76 |
| Days of Sales Outstanding | 42.91 | 29.82 | 47.59 | 31.38 | 34.85 |
| Days of Inventory Outstanding | 21.71 | 25.11 | 28.61 | 30.87 | 23.12 |
| Days of Payables Outstanding | 12.68 | 12.47 | 22.00 | 21.52 | 21.21 |
| Operating Cycle | 64.63 | 54.92 | 76.19 | 62.25 | 57.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.18 | 1.35 | -0.40 | -1.72 | -3.93 |
| Free Cash Flow Per Share | -0.33 | 1.03 | -0.42 | -1.74 | -3.99 |
| Dividend Paid and CapEx Coverage Ratio | -1.22 | 4.16 | -33.14 | -60.25 | -64.24 |
| Capital Expenditure Coverage Ratio | -1.22 | 4.16 | -33.14 | -60.25 | -64.24 |
| Operating Cash Flow Coverage Ratio | -0.05 | 0.31 | -0.70 | -1.03 | -1.16 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.04 | -0.11 | -0.23 | -0.54 |
| Free Cash Flow Yield | -4.00% | 5.04% | -22.00% | -172.70% | -88.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.56 | -80.95 | -5.22 | -0.53 | -1.18 |
| Price-to-Sales (P/S) Ratio | 0.43 | 0.62 | 0.53 | 0.14 | 0.62 |
| Price-to-Book (P/B) Ratio | 0.81 | 1.94 | 2.07 | 0.71 | 15.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -24.98 | 19.86 | -4.55 | -0.58 | -1.13 |
| Price-to-Operating Cash Flow Ratio | -45.53 | 15.08 | -4.68 | -0.59 | -1.15 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.87 | 0.06 | 0.01 | 0.08 |
| Enterprise Value Multiple | -15.90 | 20.73 | -10.34 | -1.00 | -1.94 |
| Enterprise Value | 31.76M | 61.23M | 48.54M | 16.23M | 54.07M |
| EV to EBITDA | -15.90 | 20.73 | -10.34 | -1.00 | -1.94 |
| EV to Sales | 0.46 | 0.60 | 0.58 | 0.22 | 0.87 |
| EV to Free Cash Flow | -26.45 | 19.19 | -5.01 | -0.94 | -1.59 |
| EV to Operating Cash Flow | -48.20 | 14.57 | -5.16 | -0.96 | -1.61 |
| Tangible Book Value Per Share | 7.34 | 6.91 | 0.41 | 1.34 | 0.19 |
| Shareholders’ Equity Per Share | 10.28 | 10.49 | 0.91 | 1.43 | 0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 19.25 | 32.68 | 3.58 | 7.38 | 7.26 |
| Net Income Per Share | -1.48 | -0.15 | -0.36 | -1.89 | -3.83 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.27 | -0.62 | 1.37 | 1.12 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.04 | 0.11 |
| SG&A to Revenue | 236.59 | 0.17 | 0.15 | 0.21 | 0.25 |
| Stock-Based Compensation to Revenue | 0.03 | 0.01 | 0.01 | 0.00 | 0.02 |
| Income Quality | 0.12 | -8.75 | 1.12 | 0.91 | 1.03 |
Currency in USD

